Cyabra Plans SPAC IPO with Trailblazer Merger Corporation I at $70M Valuation

2 min read
Cyabra Plans SPAC IPO with Trailblazer Merger Corporation I at $70M Valuation

Cyabra announced a definitive agreement for a business combination with Trailblazer Merger Corporation I, a special purpose acquisition company. The merger is expected to result in Cyabra being publicly listed on NASDAQ. Cyabra's technology, developed by veterans from Israeli special operations, uses sophisticated algorithms and advanced data analytics to identify automated bot campaigns spreading misinformation across social media platforms.

Related startups

— Dan Brahmy (@DanBrahmy) July 23, 2024

The spread of disinformation is considered one of the most significant short-term risks facing humanity, according to the World Economic Forum's 2024 Global Risks Report. The economic impact of disinformation is estimated at $78 billion. Cyabra's tools are being used by corporations and governments worldwide to detect and mitigate disinformation attacks, protecting citizens and brands from increasingly sophisticated campaigns.

The transaction values Cyabra at a total enterprise value of $70 Million at signing. Upon closing, expected in the first quarter of 2025, the combined company will operate as Cyabra and be listed on NASDAQ. The deal has been unanimously approved by both companies' Boards of Directors and is subject to stockholder approval and other customary closing conditions.

Cyabra was founded in 2017 by Dan Brahmy and Ido Shraga. The startup has raised $16 million in venture capital funding from investors including TAU Ventures, OurCrowd, Founders Fund, Alabaster, Harpoon Ventures, Accomplice, and Red Shepherd Ventures. Their latest funding round closed in the beginning of the year, $5.7 million, led by OurCrowd.

© 2024 StartupHub.ai. All rights reserved. Do not enter, scrape, copy, reproduce, or republish this article in whole or in part. Use as input to AI training, fine-tuning, retrieval-augmented generation, or any machine-learning system is prohibited without written license. Substantially-similar derivative works will be pursued to the fullest extent of applicable copyright, database, and computer-misuse laws. See our terms.